Dr Maruthur, of Johns Hopkins Medicine, talks about how the concept of "holistic" patient care continues to expand in the management of persons with T2D.
The American Diabetes Association and the European Association for the Study of Diabetes in late September released a new consensus report on management of hyperglycemia in persons with type 2 diabetes.
The "holistic, person-centered" approach to T2D management encouraged by the statement's guidance incorporates the most recent and in several cases novel information published since the last update in 2019, including data on:
Nisa Maruthur, MD, MHS, is a primary care clinician and a member of the US writing committee for the concensus report and in this video talks with Patient Care® about the concept of holistic care for T2D that moves beyond hyperglycemia as the central focus.
Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension
September 9th 2025Zilebesiran’s twice-yearly dosing and sustained BP reductions could offer a new therapeutic approach for adults with resistant hypertension and high CV risk who are uncontrolled on current SOC regimens.
Oral PCSK9 Inhibitor Enlicitide Meets All End Points in Phase 3 Hypercholesterolemia Trial
September 2nd 2025At week 24, patients receiving once-daily enlicitide demonstrated statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo.